Evidence map›Paper›PMID 28840270›Full record

ArticleInternational urogynecology journal2018

Natural history of pelvic organ prolapse in symptomatic patients actively seeking treatment.

Javier Pizarro-Berdichevsky, Ali Borazjani, Alejandro Pattillo, Marco Arellano, Jianbo Li, Howard B Goldman

Abstract read
PubMed Publisher
In one paragraph

Article in International urogynecology journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Timing of recurrence after surgery in pelvic organ prolapse.International urogynecology journal · 2021
    Article
  5. Article
  6. Article
  7. Impact of COVID-19 in Female Urology.International braz j urol : official journal of the Brazilian Society of Urology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Javier Pizarro-BerdichevskyUrogynecology Unit, H. Dr. Sotero del Rio, Santiago, Chile. jpizarro@med.puc.cl.ORCID http://orcid.org/0000-0002-8614-4480
Ali BorazjaniDepartment of Biomedical Engineering, Cleveland Clinic, Cleveland, OH, USA.
Alejandro PattilloUrogynecology Unit, H. Dr. Sotero del Rio, Santiago, Chile.
Marco ArellanoUrogynecology Unit, H. Dr. Sotero del Rio, Santiago, Chile.
Jianbo LiQuantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
Howard B GoldmanGlickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Cleveland Clinic · USComplejo Asistencial Sótero del Río · CLPontificia Universidad Católica de Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisAt our institution many symptomatic patients must wait months or years for surgery. Our aim was to determine the rates of clinically significant pelvic organ prolapse (POP) progression and identify risk factors associated with POP progression.

methodsData from a prospectively maintained database of POP patients evaluated between 2008 and 2013 were analyzed. Women with symptomatic POP and two or more POP-Q examinations prior to surgery were included. POP progression was defined as having any of the POP-Q points Aa, Ba, C, D, Ap or Bp above the hymen at the baseline examination and at or below the hymen at the follow-up examination. Multivariable logistic analysis was preformed and the results are presented as odds ratios (OR) with 95% confidence intervals (CI).

resultsOf consecutive patients evaluated between July 2008 and June 2013, 388 met the inclusion criteria and were included. The median time between the POP-Q examinations was 9.9 months (IQR 7.8 to 13.8 months). The POP progression rate was 29.1% (95% CI 24.6-33.6%). Predictors of progression included age (OR 1.7, 95% CI 1.01-2.87) and the baseline status of points Ba, C, Bp and gH (OR 1.91, 95% CI 1.01-3.62; OR 0.53, 95% CI 0.3-0.94; OR 0.54, 95% CI 0.32-0.93; OR 2.15, 95% CI 1.13-4.1; respectively). POP-Q point correlations showed that anterior and posterior compartment points evolve with apical compartment points and gH evolves with both the anterior compartment and the apex.

conclusionsUp to 29.1% of symptomatic patients with POP showed clinically significant progression over a median follow-up of 9.9 months. The likelihood of progression was not significantly associated with time. Those ≥60 years of age as well as those with point Ba ≥4 cm or gH ≥5 cm at baseline were at increased risk of POP progression.

Indexed as

Quality of LifeAgedChileDisease ProgressionFemaleHumansMiddle AgedPelvic FloorPelvic Organ ProlapseProspective StudiesSurveys and QuestionnairesNatural historyObservationPelvic organ prolapseRisk factors

Identifiers

PMID28840270
OpenAlexW2748162927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.